Quantitative time-resolved chemoproteomics reveals that stable O-GlcNAc regulates box C/D snoRNP biogenesis

Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6749-E6758. doi: 10.1073/pnas.1702688114. Epub 2017 Jul 31.

Abstract

O-linked GlcNAcylation (O-GlcNAcylation), a ubiquitous posttranslational modification on intracellular proteins, is dynamically regulated in cells. To analyze the turnover dynamics of O-GlcNAcylated proteins, we developed a quantitative time-resolved O-linked GlcNAc proteomics (qTOP) strategy based on metabolic pulse-chase labeling with an O-GlcNAc chemical reporter and stable isotope labeling with amino acids in cell culture (SILAC). Applying qTOP, we quantified the turnover rates of 533 O-GlcNAcylated proteins in NIH 3T3 cells and discovered that about 14% exhibited minimal removal of O-GlcNAc or degradation of protein backbones. The stability of those hyperstable O-GlcNAcylated proteins was more sensitive to O-GlcNAcylation inhibition compared with the more dynamic populations. Among the hyperstable population were three core proteins of box C/D small nucleolar ribonucleoprotein complexes (snoRNPs): fibrillarin (FBL), nucleolar protein 5A (NOP56), and nucleolar protein 5 (NOP58). We showed that O-GlcNAcylation stabilized these proteins and was essential for snoRNP assembly. Blocking O-GlcNAcylation on FBL altered the 2'-O-methylation of rRNAs and impaired cancer cell proliferation and tumor formation in vivo.

Keywords: O-GlcNAcylation; metabolic labeling; protein stability; proteomics; snoRNP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosamine / chemistry
  • Acetylglucosamine / metabolism*
  • Animals
  • Antibiotics, Antineoplastic / pharmacology
  • Cell Survival / drug effects
  • Chromosomal Proteins, Non-Histone / genetics
  • Chromosomal Proteins, Non-Histone / metabolism
  • Doxorubicin / pharmacology
  • HeLa Cells
  • Humans
  • Isotope Labeling / methods
  • MCF-7 Cells
  • Male
  • Methylation
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • NIH 3T3 Cells
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Protein Processing, Post-Translational
  • Proteome / genetics
  • Proteome / metabolism*
  • Proteomics / methods*
  • RNA, Ribosomal / genetics
  • RNA, Ribosomal / metabolism
  • Ribonucleoproteins, Small Nucleolar / genetics
  • Ribonucleoproteins, Small Nucleolar / metabolism*
  • Xenograft Model Antitumor Assays

Substances

  • Antibiotics, Antineoplastic
  • Chromosomal Proteins, Non-Histone
  • Proteome
  • RNA, Ribosomal
  • Ribonucleoproteins, Small Nucleolar
  • fibrillarin
  • Doxorubicin
  • Acetylglucosamine